We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer, Onyx’s Nexavar Receives Japanese Approval to Treat Liver Cancer
Bayer, Onyx’s Nexavar Receives Japanese Approval to Treat Liver Cancer
May 20, 2009
Bayer HealthCare and Onyx Pharmaceuticals have added Japan to the more than 70 countries to approve their drug Nexavar to treat unresectable hepatocellular carcinoma (HCC).